Espinoza Octavio bought LGND
May 17, 2024 · Form 4 insider transaction
Espinoza Octavio bought 206 shares of Ligand Pharmaceuticals Incorporated at $57.22 per share, a transaction worth $11.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
206
Price
$57.22
Total value
$11.8K
InsiderEspinoza Octavio
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 17, 2024
Filing dateMay 17, 2024
Shares owned after21,824
OwnershipDirect
10b5-1 planNo
AmendedNo